The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of atezolizumab monotherapy versus pembrolizumab monotherapy for first-line (1L) treatment of metastatic non-small cell lung cancer (mNSCLC).
 
Chia-Wei Lin
Employment - Amgen; Genentech
Stock and Other Ownership Interests - Genentech/Roche
 
Katherine Rosettie
Consulting or Advisory Role - Bayer (Inst); Genentech (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Mallinckrodt (Inst); Pfizer (Inst); Roche (Inst)
 
Pinar Bilir
Consulting or Advisory Role - Genentech (Inst)
 
Hazal Celik
Employment - Roche
Travel, Accommodations, Expenses - Roche
 
Seye Abogunrin
Employment - F. Hoffmann LaRoche
Research Funding - F. Hoffmann LaRoche (Inst)
Travel, Accommodations, Expenses - F. Hoffmann LaRoche
 
Sarika Ogale
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche